Evidence map›Paper›PMID 42132401›Full record

ReviewChemistry (Weinheim an der Bergstrasse, Germany)2026

Chiral Analysis for High-Throughput Reaction Screening: Recent Advances in Accelerating Asymmetric Catalysis Discovery.

Nijia Yu, Yanchuan Zhao

Abstract readReview
In one paragraph

Review in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nijia YuState Key Laboratory of Fluorine and Nitrogen Chemistry, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
Yanchuan ZhaoState Key Laboratory of Fluorine and Nitrogen Chemistry, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.ORCID https://orcid.org/0000-0002-2903-4218

Funding

National Natural Science Foundation of China 22271305National Natural Science Foundation of China 22574168
6 · The paper itself

Abstract

The widespread adoption of high-throughput experimentation (HTE) has transformed asymmetric catalysis by enabling the parallel execution of numerous reactions to systematically explore chemical space instead of relying on isolated trial and error. Currently, the overall efficiency of this process is limited by analytical readouts rather than reaction setups. Specifically, the rapid and reliable determination of enantiomeric excess (ee) from complex crude mixtures remains a primary bottleneck. To address this bottleneck, recent advancements in chiral analytical methodologies offer solutions through either serial analysis to shorten individual measurement times and increase information density or parallel analysis to multiplex signals for formats using microplates. These techniques span chromatography, spectroscopy, mass spectrometry, and nuclear magnetic resonance. Key factors in applying these methods include their compatibility with multiple substrates, robustness against matrix interference, and the ability to balance speed with accuracy, which allow for earlier evaluation of substrate generality and minimizes bias towards a single substrate. This proactive approach ultimately generates high-dimensional datasets that effectively guide the optimization of catalysts and reaction conditions toward universally applicable asymmetric transformations. In this review, we summarize these recent advancements in high-throughput chiral analytical methodologies and highlight their profound impact on accelerating discovery in the field of asymmetric catalysis.

Indexed as

asymmetric catalysischiral analysisenantiomeric excess determinationhigh‐throughput screeningreaction discovery

Identifiers

PMID42132401
PMCPMC13505679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.